FDA Drug Center Head Expected to Leave After Commissioners Departure

The US Food and Drug Administration (FDA) has announced a series of leadership changes, with the head of its drug center expected to leave after the commissioner’s exit. According to sources, the FDA is undergoing a shakeup in its top leadership positions.

In related news, the FDA has recently shuffled its top drug and biologics leaders as part of this broader reorganization effort. The agency has also seen the departure of one of its top officials, who was fired from their position.

Additionally, the acting leader of the FDA has been called upon to explain their past work with Planned Parenthood to abortion opponents. This development highlights the complexities and challenges faced by the agency in navigating sensitive issues related to healthcare policy.

The details of these changes are still emerging, but they indicate a significant shift within the FDA’s leadership structure. The agency’s future direction remains uncertain at this time.

Source: Google News World